As shown in Supplementary Table S1, we summarize the effects of TMPT, NUDT15, ITPA, and MRP4 polymorphisms on the clinical outcomes of thiopurines in ALL pediatric patients. The gene discussed is ITPA; the disease is acute lymphoblastic leukemia.